Transoral robotic surgery for early T classification hypopharyngeal cancer
- PMID: 26559383
- DOI: 10.1002/hed.24160
Transoral robotic surgery for early T classification hypopharyngeal cancer
Abstract
Background: For hypopharyngeal cancer, transoral robotic surgery (TORS) has been reported as a new organ preserving treatment but outcomes are rarely reported.
Methods: From 2010 to 2013, 10 patients with early T classification pyriform sinus cancer were selected to receive TORS and conventional neck dissection. The clinical parameters, including rates of adjuvant radiotherapy, survivals, as well as organ and function preservation, were retrospectively analyzed.
Results: TORS was successful in all 10 patients, and 5 patients received adjuvant radiotherapy. After mean follow-up of 26 months, 1 patient died of distant metastasis and 1 patient died of other malignancy. There was no local recurrence and larynxes were all preserved. Eight surviving patients who were followed up continuously could receive oral intake and had a serviceable voice without tracheostomy or feeding tubes.
Conclusion: TORS is a feasible transoral approach for selected patients with early T classification hypopharyngeal cancer. The reported oncologic/functional outcomes are satisfactory. © 2015 Wiley Periodicals, Inc. Head Neck 38: 857-862, 2016.
Keywords: da Vinci robotic system; hypopharyngeal cancer; organ preservation; survival rate; transoral robotic surgery.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
Transoral robotic surgery for early glottic carcinoma involving anterior commissure: Preliminary reports.Head Neck. 2016 Jun;38(6):913-8. doi: 10.1002/hed.24354. Epub 2015 Dec 29. Head Neck. 2016. PMID: 26714200
-
Transoral robotic medial hypopharyngectomy: Surgical technique.Head Neck. 2016 Apr;38 Suppl 1:E2127-9. doi: 10.1002/hed.24360. Epub 2015 Dec 29. Head Neck. 2016. PMID: 26714289
-
Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: A French GETTEC group study.Oral Oncol. 2018 Nov;86:165-170. doi: 10.1016/j.oraloncology.2018.09.014. Epub 2018 Sep 25. Oral Oncol. 2018. PMID: 30409296
-
Transoral robotic surgery (TORS) for laryngeal and hypopharyngeal cancers.J Surg Oncol. 2015 Dec;112(7):702-6. doi: 10.1002/jso.24002. Epub 2015 Aug 12. J Surg Oncol. 2015. PMID: 26266762 Review.
-
Primary Treatment of T1-T2 Hypopharyngeal Cancer: Changing Paradigms.Adv Otorhinolaryngol. 2019;83:54-65. doi: 10.1159/000492310. Epub 2019 Feb 12. Adv Otorhinolaryngol. 2019. PMID: 30943502 Review.
Cited by
-
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update.Drugs. 2023 Feb;83(3):217-248. doi: 10.1007/s40265-023-01835-2. Epub 2023 Jan 16. Drugs. 2023. PMID: 36645621 Review.
-
Oncological and Functional Outcomes of Transoral Robotic Surgery and Endoscopic Laryngopharyngeal Surgery for Hypopharyngeal Cancer: A Systematic Review.Front Surg. 2022 Apr 7;8:810581. doi: 10.3389/fsurg.2021.810581. eCollection 2021. Front Surg. 2022. PMID: 35464886 Free PMC article.
-
Nursing Observation on the Clinical Efficacy and Toxicity of Lobaplatin Compared with Cisplatin in the Treatment of Locally Advanced Hypopharyngeal Carcinoma Based on Intelligent CT Imaging.J Healthc Eng. 2021 Jun 30;2021:9982888. doi: 10.1155/2021/9982888. eCollection 2021. J Healthc Eng. 2021. PMID: 34306603 Free PMC article. Retracted.
-
Transoral Robotic Surgery for Pharyngeal and Laryngeal Cancers-A Prospective Medium-Term Study.J Clin Med. 2021 Mar 2;10(5):967. doi: 10.3390/jcm10050967. J Clin Med. 2021. PMID: 33801167 Free PMC article.
-
A nomogram for predicting occult lymph node metastasis in early hypopharyngeal cancer with cN0.Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3515-3522. doi: 10.1007/s00405-021-06648-1. Epub 2021 Feb 10. Eur Arch Otorhinolaryngol. 2021. PMID: 33566179
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
